Immunology of viral respiratory tract infection in infancy.
about
Animal models of respiratory syncytial virus infection and diseasePathogenesis of acute respiratory illness caused by human parainfluenza virusesRespiratory syncytial virus infection in cattleA recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo.Vaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice.Clinical and epidemiological comparison of human metapneumovirus and respiratory syncytial virus in seoul, Korea, 2003-2008Progress in the development of human parainfluenza virus vaccinesAntiviral B cell and T cell immunity in the lungs.Respiratory syncytial virus fusion glycoprotein expressed in insect cells form protein nanoparticles that induce protective immunity in cotton ratsRespiratory viruses involved in influenza-like illness in a Greek pediatric population during the winter period of the years 2005-2008.Susceptibility to acute mouse adenovirus type 1 respiratory infection and establishment of protective immunity in neonatal mice.Antibodies to the central conserved region of respiratory syncytial virus (RSV) G protein block RSV G protein CX3C-CX3CR1 binding and cross-neutralize RSV A and B strains.Glucocorticoid Insensitivity in Virally Infected Airway Epithelial Cells Is Dependent on Transforming Growth Factor-β Activity.Neonatal calf infection with respiratory syncytial virus: drawing parallels to the disease in human infantsProstaglandin E2 production during neonatal respiratory infection with mouse adenovirus type 1.Human metapneumovirus small hydrophobic protein inhibits NF-kappaB transcriptional activity.A novel influenza virus hemagglutinin-respiratory syncytial virus (RSV) fusion protein subunit vaccine against influenza and RSVThe host response and molecular pathogenesis associated with respiratory syncytial virus infection.MyD88 controls human metapneumovirus-induced pulmonary immune responses and disease pathogenesis.Identification of human metapneumovirus-induced gene networks in airway epithelial cells by microarray analysis.Strategic priorities for respiratory syncytial virus (RSV) vaccine development.Prospective study of human metapneumovirus infection in children less than 3 years of age.Viral infections in lung transplant recipients.Vaccines against respiratory viral pathogens for use in neonates: opportunities and challenges.Risk of respiratory syncytial virus infection in preterm infants: reviewing the need for prevention.Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus.Contribution of common and recently described respiratory viruses to annual hospitalizations in children in South Africa.Expression of CTLA-4 (CD152) in peripheral blood T cells of children with influenza virus infection including encephalopathy in comparison with respiratory syncytial virus infection.Soluble adhesion molecules and cytokines in children affected by recurrent infections of the upper respiratory tract.Effect of genetic background and delivery route on the preclinical properties of a live attenuated RSV vaccine.
P2860
Q26801458-92DC6092-B8AB-415B-87B2-E7B4C28C9A63Q27000151-8F37210A-E658-4505-B994-A93F09EA2D81Q27014853-C64B694D-DEB6-437F-B733-1BC32A0AFD2BQ33285591-D588BB39-C2C7-4B6C-B81C-F1B561290164Q33558356-089BD47A-DC0C-4F19-B3C0-174285F81259Q33680014-235305D9-E793-42CC-BF65-CFAB99C167D2Q34209872-CE3874AC-C014-4C43-AF25-069918B1117DQ34454614-B51B0ABD-5268-4DDB-AF38-9CDBCDD951B4Q34506016-37E2CD74-E390-4D59-A8A1-6CC04E630858Q34631591-0D7B8362-A025-4194-A39E-99D6091FBE71Q35867972-A0072C72-F87B-4FEE-B963-8852EFA2F9E7Q36005114-9FE4D70C-A1B2-46DA-B4E4-DA0D6D39526EQ36238505-239689E2-3735-48FF-9042-6E80FDD32F9AQ36482799-85E4A352-B5D8-40FA-B32F-5235DA37A53FQ36609481-8C73C9C8-D659-43CA-BA53-EEB281459A8BQ36845670-252674A5-C233-448E-8DF8-114AA6A5159DQ37252918-CBB026B7-12A2-4F59-A165-1B162761A1E8Q37263779-CD1395C5-EE65-4104-803C-C9E86A50BACDQ37286394-B0CD4F48-CE6B-4C5D-9334-FBCCA19ADB64Q37421827-74989196-8E49-46D0-9539-99DF26624CDEQ37572640-38CA23CB-2518-4156-8D8E-DD91C7108E34Q37575213-B409CD01-7BEF-430C-A017-E8C150D5759FQ37721885-47560ADA-2883-4628-AAD3-C7E14358BEA2Q38269845-916B6C41-9C21-4FF9-A0BE-A9E4495FA29CQ38604949-2FEEBB42-9B48-4A9D-9855-2FC8EE1EA296Q42106072-9558409A-3FBF-4638-8742-5BD9B8DB5A23Q43865728-4FE1C7DB-5348-44CC-8DAA-0643B547BD9DQ45627030-1B172561-1B08-4C85-B5EB-12655B0D9724Q48033871-4E6B9D7E-7869-42D5-89C2-4B3C62BCC95FQ55317724-7DAAAFF8-5674-41A6-8B87-5B0D4324831F
P2860
Immunology of viral respiratory tract infection in infancy.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Immunology of viral respiratory tract infection in infancy.
@ast
Immunology of viral respiratory tract infection in infancy.
@en
type
label
Immunology of viral respiratory tract infection in infancy.
@ast
Immunology of viral respiratory tract infection in infancy.
@en
prefLabel
Immunology of viral respiratory tract infection in infancy.
@ast
Immunology of viral respiratory tract infection in infancy.
@en
P1476
Immunology of viral respiratory tract infection in infancy.
@en
P2093
John V Williams
P304
P356
10.1016/S1526-0542(03)00033-2
P577
2003-06-01T00:00:00Z